$2.27
0.104.84%
Last update: Dec 16, 10:25 AM
Comments
Loading...
Outlook Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:OTLK | Benzinga
Outlook Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Dec 30
EPS Estimate
$-0.240
Quarterly Revenue Estimate
$5.96M
Annual Revenue
(as of Jun 30)
(as of Jun 30)
$1.51M
Analyze the earnings history of Outlook Therapeutics using advanced sorting and filters.
Outlook Therapeutics (OTLK) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-08-14 | $-0.44 | $-0.40 | -10.0 % |
| Q2 | 2025-05-15 | $-0.40 | $-0.55 | 27.3 % |
| Q1 | 2025-02-14 | $-0.89 | $-0.52 | -71.2 % |
| Q4 | 2024-12-27 | $-0.94 | $-0.85 | -10.6 % |
Outlook Therapeutics (OTLK) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-08-14 | $1.51M | $2.02M | -25.4 % |
| Q2 | 2025-05-15 | $0 | $702.60K | -100.0 % |
| Q4 | 2021-12-22 | $0 | $300.00K | -100.0 % |
| Q3 | 2021-08-13 | $0 | $320.00K | -100.0 % |
FAQ
When is Outlook Therapeutics (NASDAQ:OTLK) reporting earnings?
Outlook Therapeutics (OTLK) is scheduled to report earnings on February 13, 2026. The last reported earnings were for reported on August 14, 2025 for Q3.
What were the latest earnings per share (EPS) for Outlook Therapeutics (NASDAQ:OTLK)?
The Actual EPS was $-0.44, which missed the estimate of $-0.40.
What were Outlook Therapeutics’s (NASDAQ:OTLK) revenues?
The Actual Revenue was $1.5M, which missed the estimate of $2M.
Browse earnings estimates, EPS, and revenue on all stocks.
